Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Sells Ion Chromatography Assets for $2.1M

NEW YORK (GenomeWeb) – Transgenomic announced today that it has sold its ion chromatography product line and all related assets to Edge BioSystems for roughly $2.1 million in cash.

Under the deal, Edge, which manufactures and distributes DNA sequencing sample preparation and clean-up products, acquired all of Transgenomics' ion chromatography products, licenses, technology, know-how, trademarks, and inventory.

Additional terms of the arrangement were not disclosed.

"An important part of our revitalization strategy is to selectively monetize non-core legacy businesses and product lines so that we can focus our resources on commercialization of [our] multiplexed ICE COLD-PCR for high-value, high-growth clinical applications such as liquid biopsies for targeted cancer therapy and patient monitoring," Transgenomic President and CEO Paul Kinnon said in a statement. "Transgenomic will continue to pursue opportunities to optimize our asset deployment and product mix, and we expect to complete additional asset monetizations in the coming months."

About a year ago, Transgenomic divested its Surveyor Nuclease technology and assets, used to detect mutations and polymorphisms in DNA from different organisms, to Integrated DNA Technologies for at least $4.25 million.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.